Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37082
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBATEN, Evert-
dc.contributor.authorVan der Aa, F.-
dc.contributor.authorGOETHUYS, Hans-
dc.contributor.authorSlabbaert, K.-
dc.contributor.authorARIJS, Ingrid-
dc.contributor.authorVAN RENTERGHEM, Koenraad-
dc.date.accessioned2022-03-30T09:16:16Z-
dc.date.available2022-03-30T09:16:16Z-
dc.date.issued2021-
dc.date.submitted2022-03-25T10:26:48Z-
dc.identifier.citationThe Journal of urology, 205 (6) , p. 1748 -1752-
dc.identifier.issn0022-5347-
dc.identifier.issn1527-3792-
dc.identifier.urihttp://hdl.handle.net/1942/37082-
dc.description.abstractPurpose: We sought to determine whether omitting antimicrobial prophylaxis is safe in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative catheter. Materials and Methods: We conducted a multicenter randomized controlled trial from September 17, 2017 until December 31, 2019 in 5 hospitals. Patients with pyuria (>100 white blood cells/ml) and a preoperative indwelling catheter were excluded. Postoperative fever was defined as a body temperature >= 38.3C. A noninferiority design was used with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (antimicrobial prophylaxis group) - E (no antimicrobial prophylaxis group) >=Delta (6% noninferiority margin). A multivariable, logistic regression was performed regarding posttransurethral resection of the prostate fever and antimicrobial prophylaxis with co-variates: (clot-)retention and operating time. The R Project (R) for statistical computing was used and a p value of 0.05 was considered as statistically significant. Results: Of the patients 474 were included for multivariable analysis and 211/ 474 (44.5%) received antimicrobial prophylaxis vs 263/474 (55.5%) patients without antimicrobial prophylaxis. Antibiotics were fluoroquinolones in 140/211 (66.4%), cephazolin in 58/211 (27.5%) and amikacin in 13/211 (6.2%) patients. Fever occurred in 9/211 (4.4%) patients with antimicrobial prophylaxis vs 13/263 (4.9%) without antimicrobial prophylaxis (p=0.8, risk difference 0.006 [95% CI -0.003-0.06, relative risk 1.16]). We were able to exclude a meaningful increase in harm associated with omitting antimicrobial prophylaxis (p=0.4; adjusted risk difference 0.016 [95% CI -0.02-0.05]). Conclusions: Our data demonstrate the safety of omitting antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative indwelling catheter.-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.rights2021 by American Urological Association Education and Research, Inc.-
dc.subject.othertransurethral resection of prostate-
dc.subject.otherrandomized controlled trial-
dc.subject.otherfever-
dc.subject.otherdrug resistance-
dc.subject.othermicrobialantibiotic prophylaxis-
dc.titleAntimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial-
dc.typeJournal Contribution-
dc.identifier.epage1752-
dc.identifier.issue6-
dc.identifier.spage1748-
dc.identifier.volume205-
local.format.pages5-
local.bibliographicCitation.jcatA1-
dc.description.notesBaten, E (corresponding author), AZ Diest UHasselt, Associatie Urol Hageland RZ Tienen, Kapellekensweg 10, Kessel Lo, Belgium.-
dc.description.notesEvert.baten@gmail.com-
local.publisher.placeTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1097/JU.0000000000001638-
dc.identifier.pmid33560163-
dc.identifier.isiWOS:000760589000043-
dc.identifier.eissn1527-3792-
local.provider.typewosris-
local.description.affiliation[Baten, E.; Slabbaert, K.] Associatie Urol Hageland, Tielt Winge, Belgium.-
local.description.affiliation[Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Leuven, Belgium.-
local.description.affiliation[Goethuys, H.] Ziekenhuis Oost Limburg, Genk, Belgium.-
local.description.affiliation[Arijs, I; van Renterghem, K.] Ctr Canc Biol, Leuven, Belgium.-
local.description.affiliation[Baten, E.; van Renterghem, K.] Univ Hasselt, Hasselt, Belgium.-
local.description.affiliation[van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Hasselt, Belgium.-
local.uhasselt.internationalno-
item.fulltextNo Fulltext-
item.contributorBATEN, Evert-
item.contributorVan der Aa, F.-
item.contributorGOETHUYS, Hans-
item.contributorSlabbaert, K.-
item.contributorARIJS, Ingrid-
item.contributorVAN RENTERGHEM, Koenraad-
item.fullcitationBATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbaert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial. In: The Journal of urology, 205 (6) , p. 1748 -1752.-
item.accessRightsClosed Access-
item.validationecoom 2023-
crisitem.journal.issn0022-5347-
crisitem.journal.eissn1527-3792-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.